CICC
NVO

Capital Investment Counsel (Colorado)’s Novo Nordisk NVO Stock Holding History

Capital Investment Counsel (Colorado)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-73,253
Closed -$3.73M – 151
2025
Q4 		$3.73M Buy
+73,253
New +$3.75M 0.52% 73

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Capital Investment Counsel (Colorado)'s NVO Position: Q1 2026 in Review

Capital Investment Counsel (Colorado) sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 73,253 shares — an estimated $3.73M sold.

Capital Investment Counsel (Colorado) first reported a position in NVO in Q4 2025 and held it in 1 quarter. The position peaked at $3.73M in Q4 2025. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Capital Investment Counsel (Colorado) reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Capital Investment Counsel (Colorado) sold 73,253 Novo Nordisk shares in Q1 2026, an estimated $3.73M.
  • Capital Investment Counsel (Colorado) first reported a position in Novo Nordisk in Q4 2025 and held it in 1 quarter.
  • Capital Investment Counsel (Colorado)'s Novo Nordisk position peaked at $3.73M in Q4 2025.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Capital Investment Counsel (Colorado)'s 13F filing for Q1 2026, filed 23 Apr 2026.